Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that a second philanthropic ...
Leftist Democrats are using party labels to mask what should be a genuine debate about policy direction — and steal seats in ...
Grocery stores can use shoppers’ personal data to charge different customers different prices, a practice known as ...
Reported positive FDA Type 2a meeting supporting ABP-450’s comparative analytical strategy under the 351(k) regulatory pathway - - Strengthened balance sheet through financing transactions and ...
Conservative Christian advocacy organization One Million Moms (OMM) is urging its supporters to demand warnings about LGBTQ+ ...
(Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...
Dawn Richard, Valerie June will perform at the Libera Awards, Universal Music expands its mental health efforts, BMG-Concord ...
A federal judge has blocked the Trump administration's demands for confidential transgender patient information from Rhode ...
Thank you, operator, and thank you all for joining us for our first quarter 2026 earnings conference call. I will begin with ...
Broadcom escalated its dispute with European Union (EU) antitrust regulators in ​a case related to its VMware partner ...
Q1 2026 Earnings Call May 14, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen ...
Iopofosine I-131 achieved an overall response rate of 83.6% and a major response rate of 61.8% in patients with relapsed or ...